Researchers have found that key brain cells may be damaged in overdose, and OUD itself resembles near-drowning victims. Serial neurological evaluations and neurorehab could help.
Heeding the recommendation of an independent data monitoring committee, Calcimedica Inc. said it is discontinuing the phase II study testing calcium release-activated calcium channel inhibitor Auxora ...
Clinical Trials Arena on MSN
CalciMedica’s stock drops 75% on acute kidney injury trial termination
The biopharma will now evaluate how it can safely progress Auxora’s development in AKI.
Stocktwits on MSN
CALC stock slumped 76% on Wednesday — here’s why
According to the company, the committee said that the safety concerns warrant reevaluation of the study design, particularly ...
CalciMedica shares fell after the company stopped its Phase 2 KOURAGE trial for Auxora due to safety concerns.
CalciMedica shares were 82% lower, at 91 cents, after the company said it was discontinuing its Phase 2 clinical trial evaluating Auxora in patients with Stage 2 or Stage 3 acute kidney injury with ...
CalciMedica had been evaluating the therapy, called Auxora, in the Kourage trial of patients with stage 2 or 3 AKI with ...
A significant medical achievement was recorded at Sultan Qaboos University Hospital in the management of acute poisoning. A ...
Diane Ladd's cause of death has been revealed two weeks after the Academy Award-nominated actress passed away at the age of 89. On Monday, People magazine obtained a death certificate that stated Ladd ...
Two weeks after the passing of Oscar-nominated actress Diane Ladd, her cause of death has been confirmed as chronic hypoxic respiratory failure. Ladd’s cause of death was listed on her death ...
New details have emerged regarding Diane Ladd’s death at age 89. The Oscar-nominated actress’ cause of death was ruled as acute on chronic hypoxic respiratory failure, per a death certificate obtained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results